The estimated Net Worth of William Banyai is at least $56.7 Milione dollars as of 3 May 2024. Dr Banyai owns over 798 units of Twist Bioscience Corp stock worth over $15,312,540 and over the last 6 years he sold TWST stock worth over $40,783,918. In addition, he makes $628,117 as Sr. VP of Advanced Devel. e GM of Data Storage & Director at Twist Bioscience Corp.
Dr has made over 45 trades of the Twist Bioscience Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 798 units of TWST stock worth $29,630 on 3 May 2024.
The largest trade he's ever made was exercising 28,181 units of Twist Bioscience Corp stock on 13 October 2021 worth over $200,367. On average, Dr trades about 6,507 units every 20 days since 2018. As of 3 May 2024 he still owns at least 345,188 units of Twist Bioscience Corp stock.
You can see the complete history of Dr Banyai stock trades at the bottom of the page.
Dr. William Charles Banyai Ph.D. is the Sr. VP of Advanced Devel., GM of Data Storage & Director at Twist Bioscience Corp.
As the Sr. VP of Advanced Devel. e GM of Data Storage & Director of Twist Bioscience Corp, the total compensation of Dr D at Twist Bioscience Corp is $628,117. There are 8 executives at Twist Bioscience Corp getting paid more, with Emily Leproust having the highest compensation of $8,126,160.
Dr D is 66, he's been the Sr. VP of Advanced Devel. e GM of Data Storage & Director of Twist Bioscience Corp since . There are no older and 23 younger executives at Twist Bioscience Corp.
William's mailing address filed with the SEC is C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080.
Over the last 6 years, insiders at Twist Bioscience Corp have traded over $141,837,821 worth of Twist Bioscience Corp stock and bought 168,550 units worth $2,482,088 . The most active insiders traders include Fred B Craves, Keith Crandell e Emily M. Leproust. On average, Twist Bioscience Corp executives and independent directors trade stock every 8 days with the average trade being worth of $465,824. The most recent stock trade was executed by Dennis Cho on 6 September 2024, trading 275 units of TWST stock currently worth $10,769.
at twist bioscience, our expertise is synthetic dna. we have developed a proprietary semiconductor-based synthetic dna manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. by synthesizing dna on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic dna production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. the twist bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. for more information, please visit www.twistbioscience.com .
Twist Bioscience Corp executives and other stock owners filed with the SEC include: